Skip to main content
. 2021 Mar 11;9:630712. doi: 10.3389/fcell.2021.630712

FIGURE 3.

FIGURE 3

SHP2 mutation in bone marrow microenvironment promotes myeloproliferative neoplasm. PTPN11 mutation induced by Prx1-cre, Nestin-cre, Osterix-cre, and Lepr-cre in mesenchymal stem cells promotes tumorigenicity of hematopoietic stem cells, whereas PTPN11 mutation induced by VE-Cadherin-cre in endothelial cells and Oc-cre in osteoblasts shows no myeloproliferative neoplasm formation-promoting effect.